|
|
|
|
FOCUS ON FACILITIES DESIGN |
|
|
|
By Herman and Erich Bozenhardt | After decades of helping to rescue biotech and pharma companies from environmental monitoring excursions, Herman and Erich Bozenhardt bring this discussion about specific problems you should avoid. |
|
|
| Steps For Proper Cleaning Validation | e-book | By Michael Moussourakis, Jeff Phillips, Stacy Silverstein, and Malcolm McLaughlin, Alconox Inc. | Examine the steps of cleaning validation for both low-volume and high-volume manufacturers and the important role these studies play. |
|
|
FACILITIES DESIGN SOLUTIONS |
|
|
|
|
|
|
FOCUS ON PROCESS ENGINEERING |
|
|
|
By Takehiro Okumura and Zeb Khan, Takeda Pharmaceuticals | Would you ever need to follow GMP standards in workspaces where GMP is not required or possible? This article digs into why, when, and how to follow the principles of GMP. |
|
|
|
|
| Developing Robust mRNA Processes In A cGMP Environment | Poster | By Clemens Jakobi, Michal Domański, and Telmo Graça, Lonza | Explore current and emerging technologies to optimize mRNA manufacturing, especially when considering commercial production and the validation of processes in a cGMP environment. |
|
|
|
|
|
|
|
| Developability Assessment Of Three Therapeutic Antibodies | Poster | By Tao Bi, Yesenia Aguilar, et al., JOINN Biologics | Review studies for three monoclonal antibody drug candidates utilizing a panel of small scale, fast, and predictive tests used to evaluate therapeutic antibodies’ developability. |
|
|
|
|
|
|
|
| LNP Formulation For mRNA delivery | Article | Cytiva | Microfluidic mixing is one of the most effective means to formulate LNPs for its scalability and reproducibility. Explore LNP formulation, polishing, sterile filtration of mRNA-LNPs, and more. |
|
|
| Prioritize Safety And Mitigate Risk In HPAPI Manufacturing | White Paper | By Dr. Karel Vervisch, Ajinomoto Bio-Pharma Services | As highly potent active pharmaceutical ingredients become increasingly common across the industry, it is critical to work with partners who use a risk-based approach to ensure safety and quality. |
|
|
|
| Scale Up Manufacturing With Engineering Biology | Article | By William Blake, Danaher Life Sciences | Could an “engineering biology” approach be the solution for biopharmaceutical leaders struggling to scale-up and meet the growing demand for advanced therapeutics? |
|
|
Connect With Bioprocess Online: |
|
|
|